rTMS strategies for the study and treatment of schizophrenia: A review

International Journal of Neuropsychopharmacology

Volumn 11, Issue 4, 2008, Pages 563-576

  Stanford, Arielle D ^a   Sharif, Zafar ^a   Corcoran, Cheryl ^a   Urban, Nina ^b   Malaspina, Dolores ^c   Lisanby, Sarah H ^a  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^b CABRINI HOSPITAL   (Australia)

^c NEW YORK UNIVERSITY   (United States)

Author keywords

Electrophysiology; Review; Schizophrenia; Transcranial magnetic stimulation; Treatment

Indexed keywords

4 AMINOBUTYRIC ACID; DOPAMINE; NEUROLEPTIC AGENT;

AUDITORY HALLUCINATION; BRAIN REGION; CLINICAL TRIAL; HUMAN; NEUROMODULATION; NEUROTRANSMISSION; PATHOPHYSIOLOGY; PHENOMENOLOGY; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA; SYMPTOMATOLOGY; TRANSCRANIAL MAGNETIC STIMULATION;

CLINICAL TRIALS AS TOPIC; HUMANS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; TRANSCRANIAL MAGNETIC STIMULATION;

EID: 44349106453     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S1461145707008309     Document Type: Review

References (114)

1. Addington D, Addington J, Maticka-Tyndale E (1994). Specificity of the Calgary Depression Scale for schizophrenics. Schizophrenia Research 11, 239-244.
2. Addington D, Addington J, Schissel B (1990). A depression rating scale for schizophrenics. Schizophrenia Research 3, 247-251.
3. Akbarian S, Huntsman MM, Kim JJ, Tafazzoli A, Potkin SG, Bunney Jr. WE, Jones EG (1995). GABAA receptor subunit gene expression in human prefrontal cortex: comparison of schizophrenics and controls. Cerebral Cortex 5, 550-560.
4. Aleman A, Sommer IE, Kahn RS (2007). Efficacy of slow repetitive transcranial magnetic stimulation in the treatment of resistant auditory hallucinations in schizophrenia: a meta-analysis. Journal of Clinical Psychiatry 68, 416-421.
5. Alexander GE, Goldman PS (1978). Functional development of the dorsolateral prefrontal cortex: an analysis utlizing reversible cryogenic depression. Brain Research 143, 233-249.
6. Andreasen N, Nasrallah HA, Dunn V, Olson SC, Grove WM, Ehrhardt JC, Coffman JA, Crossett JH (1986). Structural abnormalities in the frontal system in schizophrenia. A magnetic resonance imaging study. Archives of General Psychiatry 43, 136-144.
7. Andreasen NC (1982). Negative symptoms in schizophrenia. Definition and reliability. Archives of General Psychiatry 39, 784-788.
8. Andreasen NC, Nopoulos P, O'Leary DS, Miller DD, Wassink T, Flaum M (1999). Defining the phenotype of schizophrenia: cognitive dysmetria and its neural mechanisms. Biological Psychiatry 46, 908-920.
9. Andreasen NC, O'Leary DS, Flaum M, Nopoulos P, Watkins GL, Boles Ponto LL, Hichwa RD (1997). Hypofrontality in schizophrenia: distributed dysfunctional circuits in neuroleptic-naive patients. Lancet 349, 1730-1734.
10. Barker AT, Freeston IL, Jalinous R, Jarratt JA (1987). Magnetic stimulation of the human brain and peripheral nervous system: an introduction and the results of an initial clinical evaluation. Neurosurgery 20, 100-109.
11. Barker AT, Jalinous R, Freeston IL (1985). Non-invasive magnetic stimulation of human motor cortex. Lancet 1, 1106-1107.
12. Benes FM (2000). Emerging principles of altered neural circuitry in schizophrenia. Brain Research. Brain Research Reviews 31, 251-269.
13. Benes FM, Kwok EW, Vincent SL, Todtenkopf MS (1998). A reduction of nonpyramidal cells in sector CA2 of schizophrenics and manic depressives. Biological Psychiatry 44, 88-97.
14. Brebion G, Amador X, Smith M, Malaspina D, Sharif Z, Gorman JM (2000). Depression, psychomotor retardation, negative symptoms, and memory in schizophrenia. Neuropsychology, Neuropsychiatry, and Behavioral Neurology 13, 177-183.
15. Brunelin J, Poulet E, Bediou B, Kallel L, Dalery J, D'Amato T, Saoud M (2006). Low frequency repetitive transcranial magnetic stimulation improves source monitoring deficit in hallucinating patients with schizophrenia. Schizophrenia Research 81, 41-45.
16. Cantello R, Gianelli M, Civardi C, Mutani R (1992). Magnetic brain stimulation: the silent period after the motor evoked potential. Neurology 42, 1951-1959.
17. Carpenter Jr. WT, Buchanan RW, Kirkpatrick B, Breier AF (1999). Diazepam treatment of early signs of exacerbation in schizophrenia. American Journal of Psychiatry 156, 299-303.
18. Chen R, Samii A, Canos M, Wassermann EM, Hallett M (1997). Effects of phenytoin on cortical excitability in humans. Neurology 49, 881-883.
19. Chibbaro G, Daniele M, Alagona G, Di Pasquale C, Cannavo M, Rapisarda V, Bella R, Pennisi G (2005). Repetitive transcranial magnetic stimulation in schizophrenic patients reporting auditory hallucinations. Neuroscience Letters 383, 54-57.
20. Chung Y-C, Im E-S, Cho G-H, Ko M-H (2007). Second run of transcranial magnetic stimulation has no effects on persistent auditory hallucinations. World Journal of Biological Psychiatry 8, 48-50.
21. Cohen E, Bernardo M, Masana J, Arrufat FJ, Navarro V, Valls S, Boget T, Barrantes N, Catarineu S, Font M, Lomena FJ (1999). Repetitive transcranial magnetic stimulation in the treatment of chronic negative schizophrenia: a pilot study. Journal of Neurology, Neurosurgery & Psychiatry 67, 129-130.
22. d'Alfonso AA, Aleman A, Kessels RP, Schouten EA, Postma A, van Der Linden JA, Cahn W, Greene Y, de Haan EH, Kahn RS (2002). Transcranial magnetic stimulation of left auditory cortex in patients with schizophrenia: effects on hallucinations and neurocognition. Journal of Neuropsychiatry & Clinical Neuroscience 14, 77-79.
23. Daskalakis ZJ, Christensen BK, Chen R, Fitzgerald PB, Zipursky RB, Kapur S (2003). Effect of antipsychotics on cortical inhibition using transcranial magnetic stimulation. Psychopharmacology (Berlin) 170, 255-262.
24. Daskalakis ZJ, Christensen BK, Fitzgerald PB, Fountain SI, Chen R (2005). Reduced cerebellar inhibition in schizophrenia: a preliminary study. American Journal of Psychiatry 162, 1203-1205.
25. Davey NJ, Puri BK, Lewis HS, Lewis SW, Ellaway PH (1997). Effects of antipsychotic medication on electromyographic responses to transcranial magnetic stimulation of the motor cortex in schizophrenia. Journal of Neurology, Neurosurgery & Psychiatry 63, 468-473.
26. Esser SK, Huber R, Massimini M, Peterson MJ, Ferrarelli F, Tononi G (2006). A direct demonstration of cortical LTP in humans: a combined TMS/EEG study. Brain Research Bulletin 69, 86-94.
27. Feinsod M, Kreinin B, Chistyakov A, Klein E (1998). Preliminary evidence for a beneficial effect of low-frequency, repetitive transcranial magnetic stimulation in patients with major depression and schizophrenia. Depresion & Anxiety 7, 65-68.
28. Fitzgerald PB, Benitez J, Daskalakis JZ, Brown TL, Marston NA, de Castella A, Kulkarni J (2005). A double-blind sham-controlled trial of repetitive transcranial magnetic stimulation in the treatment of refractory auditory hallucinations. Journal of Clinical Psychopharmacology 25, 358-362.
29. Fitzgerald PB, Benitez J, Daskalakis JZ, De Castella A, Kulkarni J (2006a). The treatment of recurring auditory hallucinations in schizophrenia with rTMS. World Journal of Biological Psychiatry 7, 119-122.
30. Fitzgerald PB, Brown TL, Daskalakis ZJ, Kulkarni J (2002). A transcranial magnetic stimulation study of inhibitory deficits in the motor cortex in patients with schizophrenia. Psychiatry Research 114, 11-22.
31. Fitzgerald PB, Brown TL, Marston NA, Oxley TJ, De Castella A, Daskalakis ZJ, Kulkarni J (2003). A transcranial magnetic stimulation study of abnormal cortical inhibition in schizophrenia. Psychiatry Research 118, 197-207.
32. Fitzgerald PB, Brown TL, Marston NA, Oxley T, De Castella A, Daskalakis ZJ, Kulkarni J (2004). Reduced plastic brain responses in schizophrenia: a transcranial magnetic stimulation study. Schizophrenia Research 71, 17-26.
33. Fitzgerald PB, Fountain S, Daskalakis ZJ (2006b). A comprehensive review of the effects of rTMS on motor cortical excitability and inhibition. Clinical Neurophysiology 117, 2584-2596.
34. Fitzgerald PB, Sritharan A, Benitez J, Daskalakis ZJ, Jackson G, Kulkarni J, Egan GF (2007). A preliminary fMRI study of the effects on cortical activation of the treatment of refractory auditory hallucinations with rTMS. Psychiatry Research: Neuroimaging 155, 83-88.
35. Freedman R, Adler LE, Myles-Worsley M, Nagamoto HT, Miller C, Kisley M, McRae K, Cawthra E, Waldo M (1996). Inhibitory gating of an evoked response to repeated auditory stimuli in schizophrenic and normal subjects. Human recordings, computer simulation, and an animal model. Archives of General Psychiatry 53, 1114-1121.
36. Frith CD, Blakemore S, Wolpert DM (2000). Explaining the symptoms of schizophrenia: abnormalities in the awareness of action. Brain Research. Brain Research Reviews 31, 357-363.
37. Geller V, Grisaru N, Abarbanel JM, Lemberg T, Belmaker RH (1997). Slow magnetic stimulation of prefrontal cortex in depression and schizophrenia. Progress in Neuropsychopharmacology & Biological Psychiatry 21, 105-110.
38. Gershon AA, Dannon PN, Grunhaus L (2003). Transcranial magnetic stimulation in the treatment of depression. American Journal of Psychiatry 160, 835-845.
39. Grisaru N, Chudakov B, Yaroslavsky Y, Belmaker RH (1998). Catatonia treated with transcranial magnetic stimulation. American Journal of Psychiatry 155, 1630.
40. Guy W (1976). Clinical Global Impressions. ECDEU Assessment Manual for Psychopharmacology (pp. 218-222). Rockland, MD: National Institute of Mental Health.
41. Hajak G, Marienhagen J, Langguth B, Werner S, Binder H, Eichhammer P (2004). High-frequency repetitive transcranial magnetic stimulation in schizophrenia: a combined treatment and neuroimaging study. Psychological Medicine 34, 1157-1163.
42. Hamilton M (1960). A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry 23, 56-62.
43. Hoffman RE, Boutros N (2001). Transcranial magnetic stimulation studies of schizophrenia. Epilepsy & Behavior 2, S30-S35.
44. Hoffman RE, Boutros NN, Hu S, Berman RM, Krystal JH, Charney DS (2000). Transcranial magnetic stimulation and auditory hallucinations in schizophrenia. Lancet 355, 1073-1075.
45. Hoffman RE, Cavus I (2002). Slow transcranial magnetic stimulation, long-term depotentiation, and brain hyperexcitability disorders. American Journal of Psychiatry 159, 1093-1102.
46. Hoffman RE, Gueorguieva R, Hawkins KA, Varanko M, Boutros NN, Wu YT, Carroll K, Krystal JH (2005). Temporoparietal transcranial magnetic stimulation for auditory hallucinations: safety, efficacy and moderators in a fifty patient sample. Biological Psychiatry 58, 97-104.
47. Hoffman RE, Hampson M, Wu K, Anderson AW, Gore JC, Buchanan RJ, Constable RT, Hawkins KA, Sahay N, Krystal JH (2007). Probing the pathophysiology of auditory/verbal hallucinations by combining functional magnetic resonance imaging and transcranial magnetic stimulation. Cerebral Cortex 17, 2733-2743.
48. Hoffman RE, Hawkins KA, Gueorguieva R, Boutros NN, Rachid F, Carroll K, Krystal JH (2003). Transcranial magnetic stimulation of left temporoparietal cortex and medication-resistant auditory hallucinations. Archives of General Psychiatry 60, 49-56.
49. Holi MM, Eronen M, Toivonen K, Toivonen P, Marttunen M, Naukkarinen H (2004). Left prefrontal repetitive transcranial magnetic stimulation in schizophrenia. Schizophrenia Bulletin 30, 429-434.
50. Horacek J, Brunovsky M, Novak T, Skrdlantova L, Klirova M, Bubenikova-Valesova V, Krajca V, Tislerova B, Kopecek M, Spaniel F, Mohr P, Hoschl C (2007). Effect of low-frequency rTMS on electromagnetic tomography (LORETA) and regional brain metabolism (PET). in schizophrenia patients with auditory hallucinations. Neuropsychobiology 55, 132-142.
51. Huang YZ, Edwards MJ, Rounis E, Bhatia KP, Rothwell JC (2005). Theta burst stimulation of the human motor cortex. Neuron 45, 201-206.
52. Huber TJ, Schneider U, Rollnik J (2003). Gender differences in the effect of repetitive transcranial magnetic stimulation in schizophrenia. Psychiatry Research 120, 103-105.
53. Ichimiya T, Okubo Y, Suhara T, Sudo Y (2001). Reduced volume of the cerebellar vermis in neuroleptic-naive schizophrenia. Biological Psychiatry 49, 20-27.
54. Iyer MB, Schleper N, Wassermann EM (2003). Priming stimulation enhances the depressant effect of low-frequency repetitive transcranial magnetic stimulation. Journal of Neuroscience 23, 10867-10872.
55. Jandl M, Bittner R, Sack A, Weber B, Gunther T, Pieschl D, Kaschka WP, Maurer K (2004). Changes in negative symptoms and EEG in schizophrenic patients after repetitive Transcranial Magnetic Stimulation (rTMS): an open-label pilot study. Journal of Neural Transmission 112, 955-967.
56. Jandl M, Steyer J, Weber M, Linden DE, Rothmeier J, Maurer K, Kaschka WP (2006). Treating auditory hallucinations by transcranial magnetic stimulation: a randomized controlled cross-over trial. Neuropsychobiology 53, 63-69.
57. Jin Y, Potkin SG, Kemp AS, Huerta ST, Alva G, Thai TM, Carreon D, Bunney Jr. WE (2005). Therapeutic effects of individualized alpha frequency transcranial magnetic stimulation (αTMS) on the negative symptoms of schizophrenia. Schizophrenia Bulletin 32, 556-561.
58. Kalivas PW, Barnes CD (1993). Limbic Motor Circuits and Neuropsychiatry. Boca Raton, FL: CRC Press.
59. Kamikubo Y, Tabata T, Kakizawa S, Kawakami D, Watanabe M, Ogura A, Iino M, Kano M (2007). Postsynaptic GABAB receptor signalling enhances LTD in mouse cerebellar Purkinje cells. Journal of Physiology 585, 549-563.
60. Kay SR, Fiszbein A, Opler LA (1987). The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophrenia Bulletin 13, 261-276.
61. Kirkpatrick B, Buchanan RW, Ross DE, Carpenter Jr. WT (2001). A separate disease within the syndrome of schizophrenia. Archives of General Psychiatry 58, 165-171.
62. Kirkpatrick B, Conley RC, Kakoyannis A, Reep RL, Roberts RC (1999). Interstitial cells of the white matter in the inferior parietal cortex in schizophrenia: an unbiased cell-counting study. Synapse 34, 95-102.
63. Klein E, Kolsky Y, Puyerovsky M, Koren D, Chistyakov A, Feinsod M (1999). Right prefrontal slow repetitive transcranial magnetic stimulation in schizophrenia: a double-blind sham-controlled pilot study. Biological Psychiatry 46, 1451-1454.
64. Klimesch W, Sauseng P, Gerloff C (2003). Enhancing cognitive performance with repetitive transcranial magnetic stimulation at human individual alpha frequency. European Journal of Neuroscience 17, 1129-1133.
65. Langguth B, Eichhammer P, Zowe M, Marienhagen J, Spiessl H, Hajak G (2006). Neuronavigated transcranial magnetic stimulation and auditory hallucinations in a schizophrenic patient: monitoring of neurobiological effects. Schizophrenia Research 84, 185-186.
66. Lee SH, Kim W, Chung YC, Jung KH, Bahk WM, Jun TY, Kim KS, George MS, Chae JH (2005). A double blind study showing that two weeks of daily repetitive TMS over the left or right temporoparietal cortex reduces symptoms in patients with schizophrenia who are having treatment-refractory auditory hallucinations. Neuroscience Letters 376, 177-181.
67. Lewis DA, Gonzalez-Burgos G (2006). Pathophysiologically based treatment interventions in schizophrenia. Nature Medicine 12, 1016-1022.
68. Lewis DA, Pierri JN, Volk DW, Melchitzky DS, Woo TU (1999). Altered GABA neurotransmission and prefrontal cortical dysfunction in schizophrenia. Biological Psychiatry 46, 616-626.
69. Liddle PF (1992). Regional brain abnormalities associated with specific syndromes of persistent schizophrenic symptoms. Clinical Neuropharmacology 15 (Suppl. 1, part A), 401A-402A.
70. Lieberman JA (2006). Comparative effectiveness of antipsychotic drugs. A commentary on: Cost Utility of the Latest Antipsychotic Drugs. In Schizophrenia Study (CUtLASS 1) and Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE). Archives of General Psychiatry 63, 1069-1072.
71. Luber B, Stanford AD, Malaspina D, Lisanby SH (2007). Revisiting the backward masking deficit in schizophrenia: individual differences in performance and modeling with transcranial magnetic stimulation. Biological Psychiatry 62, 793-799.
72. Malaspina D, Goetz RR, Yale S, Berman A, Friedman JH, Tremeau F, Printz D, Amador X, Johnson J, Brown A, Gorman JM (2000). Relation of familial schizophrenia to negative symptoms but not to the deficit syndrome. American Journal of Psychiatry 157, 994-1003.
73. McCarley RW, Faux SF, Shenton ME, Nestor PG, Adams J (1991). Event-related potentials in schizophrenia: their biological and clinical correlates and a new model of schizophrenic pathophysiology. Schizophrenia Research 4, 209-231.
74. McIntosh AM, Semple D, Tasker K, Harrison LK, Owens DG, Johnstone EC, Ebmeier KP (2004). Transcranial magnetic stimulation for auditory hallucinations in schizophrenia. Psychiatry Research 127, 9-17.
75. McKenna PJ, Lund CE, Mortimer AM (1989). Negative symptoms: relationship to other schizophrenic symptom classes. British Journal of Psychiatry (Suppl.), 104-107.
76. Mogg A, Purvis R, Eranti S, Contell F, Taylor JP, Nicholson T, Brown RG, McLoughlin DM (2007). Repetitive transcranial magnetic stimulation for negative symptoms of schizophrenia: a randomized controlled pilot study. Schizophrenia Research 93, 221-228.
77. Montgomery SA, Asberg M (1979). A new depression scale designed to be sensitive to change. British Journal of Psychiatry 134, 382-389.
78. Nahas Z, Lomarev M, Roberts DR, Shastri A, Lorberbaum JP, Teneback C, McConnell K, Vincent DJ, Li X, George MS, Bohning DE (2001). Unilateral left prefrontal transcranial magnetic stimulation (TMS) produces intensity-dependent bilateral effects as measured by interleaved BOLD fMRI. Biological Psychiatry 50, 712-720.
79. Nakaya M, Ohmori K, Komahashi T, Suwa H (1997). Depressive symptoms in acute schizophrenic inpatients. Schizophrenia Research 25, 131-139.
80. Novak T, Horacek J, Mohr P, Kopecek M, Skrdlantova L, Klirova M, Rodriguez M, Spaniel F, Dockery C, Hoschl C (2006). The double-blind sham-controlled study of high-frequency rTMS (20 Hz). for negative symptoms in schizophrenia: negative results. Neuroendocrinology Letters 27, 209-213.
81. Overall JE, Gorham DR (1962). The brief psychiatric rating scale. Psychological Reports 10, 799-812.
82. Oxley T, Fitzgerald PB, Brown TL, de Castella A, Daskalakis ZJ, Kulkarni J (2004). Repetitive transcranial magnetic stimulation reveals abnormal plastic response to premotor cortex stimulation in schizophrenia. Biological Psychiatry 56, 628-633.
83. Pascual-Leone A, Tormos JM, Keenan J, Tarazona F, Canete C, Catala MD (1998). Study and modulation of human cortical excitability with transcranial magnetic stimulation. Journal of Clinical Neurophysiology 15, 333-343.
84. Pascual-Leone A, Valls-Sole J, Wassermann EM, Hallett M (1994). Responses to rapid-rate transcranial magnetic stimulation of the human motor cortex. Brain 117, 847-858.
85. Poulet E, Brunelin J, Bediou B, Bation R, Forgeard L, Dalery J, d'Amato T, Saoud M (2005). Slow transcranial magnetic stimulation can rapidly reduce resistant auditory hallucinations in schizophrenia. Biological Psychiatry 57, 188-191.
86. Prikryl R, Kasparek T, Skotakova S, Ustohal L, Kucerova H, Ceskova E (2007). Treatment of negative symptoms of schizophrenia using repetitive transcranial magnetic stimulation in a double-blind, randomized controlled study. Schizophrenia Research 95, 151-157.
87. Rollnik JD, Seifert J, Huber TJ, Becker H, Panning B, Schneider U, Emrich HM (2001). Repetitive transcranial magnetic stimulation and electroconvulsive therapy in a patient with treatment-resistant schizoaffective disorder. Depression & Anxiety 13, 103-104.
88. Saba G, Rocamora JF, Kalalou K, Benadhira R, Plaze M, Aubriot-Delmas B, Januel D (2002). Catatonia and transcranial magnetic stimulation. American Journal of Psychiatry 159, 1794.
89. Sachdev P, Loo C, Mitchell P, Malhi G (2005). Transcranial magnetic stimulation for the deficit syndrome of schizophrenia: a pilot investigation. Psychiatry and Clinical Neurosciences 59, 354-357.
90. Sanger TD, Garg RR, Chen R (2001). Interactions between two different inhibitory systems in the human motor cortex. Journal of Physiology 530, 307-317.
91. Sax KW, Strakowski SM, Keck Jr. PE, Upadhyaya VH, West SA, McElroy SL (1996). Relationships among negative, positive, and depressive symptoms in schizophrenia and psychotic depression. British Journal of Psychiatry 168, 68-71.
92. Schmahmann JD, Sherman JC (1998). The cerebellar cognitive affective syndrome. Brain 121, 561-579.
93. Schonfeldt-Lecuona C, Gron G, Walter H, Buchler N, Wunderlich A, Spitzer M, Herwig U (2004). Stereotaxic rTMS for the treatment of auditory hallucinations in schizophrenia. Neuroreport 15, 1669-1673.
94. Selemon LD, Goldman-Rakic PS (1999). The reduced neuropil hypothesis: a circuit based model of schizophrenia. Biological Psychiatry 45, 17-25.
95. Siebner HR, Dressnandt J, Auer C, Conrad B (1998). Continuous intrathecal baclofen infusions induced a marked increase of the transcranially evoked silent period in a patient with generalized dystonia. Muscle Nerve 21, 1209-1212.
96. Silbersweig DA, Stern E, Frith C, Cahill C, Holmes A, Grootoonk S, Seaward J, McKenna P, Chua SE, Schnorr L, et al. (1995). A functional neuroanatomy of hallucinations in schizophrenia. Nature 378, 176-179.
97. Simpson MD, Slater P, Deakin JF, Royston MC, Skan WJ (1989). Reduced GABA uptake sites in the temporal lobe in schizophrenia. Neuroscience Letters 107, 211-215.
98. Siris SG (1991). Diagnosis of secondary depression in schizophrenia: implications for DSM-IV. Schizophrenia Bulletin 17, 75-98.
99. Sommer IEC, Slotema CW, de Weijer AD, Blom JD, Daalman K, Neggers SF, Somers M, Hoek HW, Aleman A, Kahn RS (2007). Can fMRI-guidance improve the efficacy of rTMS treatment for auditory verbal hallucinations? Schizophrenia Research 93, 406-408.
100. Speer AM, Kimbrell TA, Wassermann EM, Repella JD, Willis MW, Herscovitch P, Post RM (2000). Opposite effects of high and low frequency rTMS on regional brain activity in depressed patients. Biological Psychiatry 48, 1133-1141.
101. Spencer KM, Nestor PG, Perlmutter R, Niznikiewicz MA, Klump MC, Frumin M, Shenton ME, McCarley RW (2004). Neural synchrony indexes disordered perception and cognition in schizophrenia. Proceedings of the National Academy of Sciences USA 101, 17288-17293.
102. Strafella AP, Paus T, Barrett J, Dagher A (2001). Repetitive transcranial magnetic stimulation of the human prefrontal cortex induces dopamine release in the caudate nucleus. Journal of Neuroscience 21, RC157.
103. Strafella AP, Paus T, Fraraccio M, Dagher A (2003). Striatal dopamine release induced by repetitive transcranial magnetic stimulation of the human motor cortex. Brain 126, 2609-2615.
104. Tamminga CA, Thaker GK, Buchanan R, Kirkpatrick B, Alphs LD, Chase TN, Carpenter WT (1992). Limbic system abnormalities identified in schizophrenia using positron emission tomography with fluorodeoxyglucose and neocortical alterations with deficit syndrome. Archives of General Psychiatry 49, 522-530.
105. Vaiva G, Cottencin O, Llorca PM, Devos P, Dupont S, Mazas O, Rascle C, Thomas P, Steinling M, Goudemand M (2002). Regional cerebral blood flow in deficit/nondeficit types of schizophrenia according to SDS criteria. Progress in Neuropsychopharmacology & Biological Psychiatry 26, 481-485.
106. Volk DW, Fritschy JM, Lewis DA (2000). Axon initial segments of pyramidal neurons immunoreactive for GABAA receptor a2 subunit in the prefrontal cortex in schizophrenia. Society for Neuroscience Abstracts 26, 1564.
107. Volk DW, Pierri JN, Fritschy JM, Auh S, Sampson AR, Lewis DA (2002). Reciprocal alterations in pre- and postsynaptic inhibitory markers at chandelier cell inputs to pyramidal neurons in schizophrenia. Cerebral Cortex 12, 1063-1070.
108. Wassermann EM (1998). Risk and safety of repetitive transcranial magnetic stimulation: report and suggested guidelines from the International Workshop on the Safety of Repetitive Transcranial Magnetic Stimulation, 5-7 June 1996. Electroencephalography and Clinical Neurophysiology 108, 1-16.
109. Wassermann EM, Lisanby SH (2001). Therapeutic application of repetitive transcranial magnetic stimulation: a review. Clinical Neurophysiology 112, 1367-1377.
110. Werhahn KJ, Kunesch E, Noachtar S, Benecke R, Classen J (1999). Differential effects on motorcortical inhibition induced by blockade of GABA uptake in humans. Journal of Physiology 517, 591-597.
111. Wible CG, Shenton ME, Hokama H, Kikinis R, Jolesz FA, Metcalf D, McCarley RW (1995). Prefrontal cortex and schizophrenia. A quantitative magnetic resonance imaging study. Archives of General Psychiatry 52, 279-288.
112. Wolkowitz OM, Pickar D (1991). Benzodiazepines in the treatment of schizophrenia: a review and reappraisal. American Journal of Psychiatry 148, 714-726.
113. Woo TU, Whitehead RE, Melchitzky DS, Lewis DA (1998). A subclass of prefrontal gamma-aminobutyric acid axon terminals are selectively altered in schizophrenia. Proceedings of the National Academy of Sciences USA 95, 5341-5346.
114. Ziemann U, Rothwell JC, Ridding MC (1996). Interaction between intracortical inhibition and facilitation in human motor cortex. Journal of Physiology 496, 873-881.